Technical Analysis for HBIO - Harvard Bioscience, Inc.

Grade Last Price % Change Price Change
B 6.64 -3.91% -0.27
HBIO closed down 3.91 percent on Wednesday, April 14, 2021, on 1.11 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: May 3
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical HBIO trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Pocket Pivot Bullish Swing Setup -3.91%
Wide Bands Range Expansion -3.91%
Overbought Stochastic Strength -3.91%
New Uptrend Bullish 0.61%
Pocket Pivot Bullish Swing Setup 0.61%
Outside Day Range Expansion 0.61%
Wide Bands Range Expansion 0.61%
Overbought Stochastic Strength 0.61%
Older End-of-Day Signals for HBIO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 20 hours ago
60 Minute Opening Range Breakdown about 20 hours ago
Down 2 % about 20 hours ago
Rose Above Previous Day's High about 21 hours ago
Down 1% about 22 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Harvard Bioscience, Inc. Description

Harvard Bioscience, Inc., together with its subsidiaries, develops, manufactures, distributes, and markets specialized products, primarily apparatus and scientific instruments used to advance life science research and regenerative medicine. It operates through two segments, Life Science Research Tools and Regenerative Medicine Device. The company's products primarily target ADMET testing and molecular biology application areas. Its ADMET testing products include absorption diffusion chambers that measure the absorption of a drug into the bloodstream; well equilibrium dialysis plate for serum protein binding assays; organ testing systems; infusion pumps; behavioral products used in neuroscience, cardiology, psychological, and respiratory studies to evaluate the effects of situational stimuli, drugs, and nutritional infusions on motor and sensory, activity, and learning and test behavior; cell injection systems; ventilators; and electroporation products. The company's molecular biology products include molecular biology spectrophotometers, DNA/RNA/protein calculators, multi-well plate readers, liquid dispensers, and amino acid analysis and gel electrophoresis systems, as well as liquid handling consumables, such as pipettes, pipette tips, autoradiography films, gloves, thermal cycler accessories, and reagents. It also distributes devices, instruments, and consumables used in experiments involving cells, tissues, organs, and animals in the fields of proteomics, physiology, pharmacology, neuroscience, cell biology, molecular biology, and toxicology; and manufactures microdialysis products, synthetic scaffolds, bioreactors, and cell biology and electrophysiology products. The company sells its products to pharmaceutical and biotechnology companies, universities, and government laboratories through distributors, catalogs, and its field sales organization and Website worldwide. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.


Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Biotechnology Biology Acid Natural Sciences Pharmacology Molecular Biology Neuroscience Dialysis Cell Biology Cardiology Regenerative Medicine Toxicology Infusion Pump Organs Physiology Specialized Products Electrophysiology Radiography Proteomics Oral Products Search Tool E Readers Dialysis Products Electrophysiology Products Electroporation Gel Electrophoresis Harvard

Is HBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 7.14
52 Week Low 2.06
Average Volume 244,770
200-Day Moving Average 4.07
50-Day Moving Average 5.33
20-Day Moving Average 6.02
10-Day Moving Average 6.26
Average True Range 0.38
ADX 28.74
+DI 34.09
-DI 12.11
Chandelier Exit (Long, 3 ATRs ) 6.00
Chandelier Exit (Short, 3 ATRs ) 6.37
Upper Bollinger Band 7.07
Lower Bollinger Band 4.98
Percent B (%b) 0.79
BandWidth 34.81
MACD Line 0.37
MACD Signal Line 0.30
MACD Histogram 0.0692
Fundamentals Value
Market Cap 258.8 Million
Num Shares 39 Million
EPS -0.12
Price-to-Earnings (P/E) Ratio -53.59
Price-to-Sales 1.42
Price-to-Book 1.91
PEG Ratio 2.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.23
Resistance 3 (R3) 7.27 7.12 7.13
Resistance 2 (R2) 7.12 6.97 7.10 7.09
Resistance 1 (R1) 6.88 6.88 6.81 6.84 7.06
Pivot Point 6.73 6.73 6.69 6.71 6.73
Support 1 (S1) 6.49 6.58 6.42 6.45 6.22
Support 2 (S2) 6.34 6.49 6.32 6.19
Support 3 (S3) 6.10 6.34 6.15
Support 4 (S4) 6.06